ACVR2B and carcinoma: The mechanism responsible for the downregulation of BMPR2 in EBNA1-expressing and EBV-infected carcinoma cells in vitro is unclear, but the fact that these cells showed robust Smad1/5/8 phosphorylation suggests that ACVR2A or ACVR2B can substitute for BMPR2.